Cytokinetics | CYTK - Ebitda


Cytokinetics reported $-107.82M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Amgen USD 5.91B 2.31B Sep/2025
Bayer EUR 1.51B 1.28B Sep/2025
Biogen USD 1.01B 456.5M Jun/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Cytokinetics USD -107.82M 45.51M Jun/2025
Eisai JPY 23.48B 14.68B Sep/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Exelixis USD 248.93M 28.02M Sep/2025
Geron USD -7.55M 8.85M Jun/2025
Halozyme Therapeutics USD 248.25M 22.74M Sep/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
Ligand Pharmaceuticals USD 20.9M 61.44M Jun/2025
Merck USD 8.39B 1.97B Sep/2025
Novartis USD 5.88B 290M Sep/2025
Pfizer USD 6.08B 351M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025